Yuandeng Luo

530 total citations
12 papers, 285 citations indexed

About

Yuandeng Luo is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Yuandeng Luo has authored 12 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Yuandeng Luo's work include RNA modifications and cancer (4 papers), Ubiquitin and proteasome pathways (3 papers) and Cancer-related gene regulation (3 papers). Yuandeng Luo is often cited by papers focused on RNA modifications and cancer (4 papers), Ubiquitin and proteasome pathways (3 papers) and Cancer-related gene regulation (3 papers). Yuandeng Luo collaborates with scholars based in China. Yuandeng Luo's co-authors include Ping Bie, Yan Jiang, Chengcheng Zhang, Yi Gong, Chuan‐Ming Xie, Lei Fang, Wei Liu, Anbin Wang, Yan Jiang and Ling Shuai and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Hepatology.

In The Last Decade

Yuandeng Luo

12 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuandeng Luo China 8 184 90 67 53 32 12 285
Atsutaka Masuda Japan 9 142 0.8× 92 1.0× 85 1.3× 51 1.0× 32 1.0× 19 279
Xiaochuang Feng China 7 216 1.2× 139 1.5× 71 1.1× 48 0.9× 30 0.9× 16 310
Junming Xu China 12 239 1.3× 140 1.6× 97 1.4× 74 1.4× 27 0.8× 27 402
Mingdian Lu China 9 198 1.1× 101 1.1× 45 0.7× 50 0.9× 19 0.6× 15 271
Chunjuan Zhao China 9 257 1.4× 194 2.2× 46 0.7× 44 0.8× 30 0.9× 12 360
Jiming Bao China 9 228 1.2× 78 0.9× 49 0.7× 53 1.0× 13 0.4× 22 373
Qiandong Zhu China 10 212 1.2× 168 1.9× 53 0.8× 45 0.8× 25 0.8× 14 309
Hongqi Shi China 9 191 1.0× 109 1.2× 97 1.4× 53 1.0× 26 0.8× 23 347
Rongjie Zhao China 9 162 0.9× 102 1.1× 60 0.9× 56 1.1× 18 0.6× 21 279
Myung‐Giun Noh South Korea 11 145 0.8× 61 0.7× 103 1.5× 61 1.2× 17 0.5× 35 297

Countries citing papers authored by Yuandeng Luo

Since Specialization
Citations

This map shows the geographic impact of Yuandeng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuandeng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuandeng Luo more than expected).

Fields of papers citing papers by Yuandeng Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuandeng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuandeng Luo. The network helps show where Yuandeng Luo may publish in the future.

Co-authorship network of co-authors of Yuandeng Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Yuandeng Luo. A scholar is included among the top collaborators of Yuandeng Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuandeng Luo. Yuandeng Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Lin, Xiaotong, Yuandeng Luo, Yi Gong, et al.. (2024). Integrated ubiquitomics characterization of hepatocellular carcinomas. Hepatology. 82(1). 42–58. 4 indexed citations
2.
Zhang, Jie, Xiaotong Lin, Hongqiang Yu, et al.. (2023). Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice. Experimental & Molecular Medicine. 55(10). 2162–2176. 16 indexed citations
3.
Luo, Yuandeng, Xiaoyu Liu, Lei Fang, et al.. (2022). Mutant Kras and mTOR crosstalk drives hepatocellular carcinoma development via PEG3/STAT3/BEX2 signaling. Theranostics. 12(18). 7903–7919. 16 indexed citations
4.
Luo, Yuandeng, Lei Fang, Hongqiang Yu, et al.. (2020). p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma. Journal of Hepatology. 74(1). 96–108. 61 indexed citations
5.
Tan, Ye, Xiaotong Lin, Yuandeng Luo, et al.. (2020). Reduced IκBα promotes hepatocellular carcinoma cell proliferation and migration via regulation of NF‑κB/Erbin axis. Oncology Letters. 20(5). 1–1. 4 indexed citations
6.
Luo, Yuandeng, Hongqiang Yu, Xiaoyu Liu, et al.. (2020). Prognostic and predicted significance of Ubqln2 in patients with hepatocellular carcinoma. Cancer Medicine. 9(12). 4083–4094. 5 indexed citations
7.
Jiang, Yan, et al.. (2019). Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1. Phytomedicine. 62. 152953–152953. 23 indexed citations
8.
Wang, Anbin, Yi Gong, Chengcheng Zhang, et al.. (2019). ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis. Journal of Experimental & Clinical Cancer Research. 38(1). 347–347. 85 indexed citations
9.
Su, Xingxing, Yuandeng Luo, Yan Jiang, et al.. (2019). PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells. Cell Death and Disease. 10(8). 595–595. 36 indexed citations
10.
Luo, Yuandeng, Jie Zhang, Lei Fang, et al.. (2019). FBXW10 promotes hepatocarcinogenesis in male patients and mice. Carcinogenesis. 41(5). 689–698. 11 indexed citations
12.
Huang, Guoyang, Jiajun Xu, Shifeng Wang, et al.. (2014). Hyperbaric Oxygen Preconditioning Induces Tolerance against Oxidative Injury and Oxygen-Glucose Deprivation by Up-Regulating Heat Shock Protein 32 in Rat Spinal Neurons. PLoS ONE. 9(1). e85967–e85967. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026